Skip to main content
SpringerLink
Log in

PIK3CA mutations in glioblastoma multiforme

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Glioblastoma multiforme WHO grade IV is the most common and malignant variant of astrocytic tumors. Loss of heterozygosity of chromosome 10 and mutations in the tumor suppressor gene PTEN on 10q are molecular hallmarks of glioblastomas. Recently, mutations were identified in PIK3CA, encoding a protein that antagonizes the function of PTEN protein in the PI3K/Akt pathway. To address the question whether an exclusive mutation pattern can be observed in PIK3CA and PTEN, we determined the frequency of mutations in both genes. All coding exons were examined by single strand confirmation polymorphism and direct sequencing. Additionally, we analyzed chromosome 10 for loss of heterozygosity and evaluated the mutational status of TP53. In 70 glioblastomas, 5 (7%) PIK3CA mutations and 10 (14%) PTEN mutations were found. All mutations in PIK3CA located to exons 1, 9 and 20, thereby supporting the concept of mutational hot spot regions. In all but one glioblastoma, mutations were seen either in PIK3CA or in PTEN. In conclusion, the frequency of PIK3CA mutations in glioblastomas appears to be much lower than initially reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Broderick DK, Di C, Parrett TJ, et al (2004) Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64:5048–5050

    Google Scholar 

  2. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655–1657

    Article  CAS  PubMed  Google Scholar 

  3. Duerr EM, Rollbrocker B, Hayashi Y, et al (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259–2264

    Article  CAS  PubMed  Google Scholar 

  4. Hartmann C, Numann A, Mueller W, et al (2004) Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer 108:839–844

    Google Scholar 

  5. Ichimura K, Bolin MB, Goike HM, et al (2000) Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 60:417–424

    CAS  PubMed  Google Scholar 

  6. Kleihues P, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system, 2nd edn. IARC Press, Lyon

  7. Knobbe CB, Reifenberger G (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3’-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507–518

    CAS  PubMed  Google Scholar 

  8. Louis DN, Deimling A von, Seizinger BR (1992) A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 141:777–782

    Google Scholar 

  9. Ma YY, Wei SJ, Lin YC, et al (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19:2739–2744

    Google Scholar 

  10. Miller CT, Moy JR, Lin L, et al (2003) Gene amplification in esophageal adenocarcinomas and Barrett’s with high-grade dysplasia. Clin Cancer Res 9:4819–4825

    Google Scholar 

  11. Racz A, Brass N, Heckel D, et al (1999) Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma. Eur J Cancer 35:641–646

    Google Scholar 

  12. Rao RD, James CD (2004) Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin Oncol 31:595–604

    Google Scholar 

  13. Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656–670

    Google Scholar 

  14. Samuels Y, Wang Z, Bardelli A, et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554

    Google Scholar 

  15. Tong CY, Hui AB, Yin XL, et al (2004) Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg Spine 100:187–193

    Google Scholar 

  16. Woenckhaus J, Steger K, Werner E, et al (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198:335–342

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropathology, Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany

    Christian Hartmann, Gesine Bartels, Claire Gehlhaar, Nikola Holtkamp & Andreas von Deimling

Authors
  1. Christian Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gesine Bartels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claire Gehlhaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nikola Holtkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas von Deimling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Hartmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartmann, C., Bartels, G., Gehlhaar, C. et al. PIK3CA mutations in glioblastoma multiforme. Acta Neuropathol 109, 639–642 (2005). https://doi.org/10.1007/s00401-005-1000-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-005-1000-1

Keywords

Search

Navigation